| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 124.674 | 101.615 | 101.771 | 137.681 | 77.762 | 71.360 | 97.564 | 112.425 | 14.729 | 9.975 |
| Total Income - EUR | 175.635 | 133.805 | 108.958 | 150.957 | 87.570 | 78.580 | 106.501 | 120.964 | 25.082 | 23.451 |
| Total Expenses - EUR | 142.856 | 116.416 | 83.073 | 121.494 | 79.341 | 64.032 | 71.970 | 94.102 | 51.978 | 52.913 |
| Gross Profit/Loss - EUR | 32.780 | 17.389 | 25.885 | 29.463 | 8.229 | 14.548 | 34.531 | 26.862 | -26.897 | -29.462 |
| Net Profit/Loss - EUR | 27.505 | 14.530 | 24.753 | 27.979 | 7.392 | 13.786 | 33.572 | 25.876 | -27.069 | -30.151 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Spil Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 163.013 | 175.160 | 166.007 | 177.519 | 158.585 | 142.537 | 133.050 | 150.293 | 138.539 | 98.379 |
| Current Assets | 86.599 | 82.655 | 143.548 | 192.790 | 221.844 | 208.136 | 211.287 | 206.621 | 106.754 | 31.989 |
| Inventories | 2.852 | 3.399 | 4.256 | 8.052 | 10.289 | 4.406 | 4.548 | 5.964 | 0 | 0 |
| Receivables | 55.116 | 47.624 | 50.577 | 81.262 | 38.149 | 21.507 | 35.600 | 32.602 | 401 | 0 |
| Cash | 28.631 | 31.632 | 88.715 | 103.475 | 173.405 | 182.223 | 171.139 | 168.055 | 106.353 | 31.989 |
| Shareholders Funds | 77.539 | 91.278 | 114.487 | 140.364 | 145.038 | 156.135 | 186.245 | 212.699 | 183.767 | 129.030 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 172.072 | 166.537 | 195.068 | 229.944 | 235.390 | 194.537 | 158.093 | 144.216 | 61.526 | 1.338 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Spil Med S.r.l.